Klotho Neurosciences, Inc.
KLTO
$1.54
$0.042.67%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -538.96% | -769.30% | -514.62% | -104.22% | -86.35% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,261.33% | -- | 2,039.10% | -- | 20,421.43% |
| Change in Net Operating Assets | -210.49% | -42.21% | -156.11% | -127.51% | 9,111.76% |
| Cash from Operations | -1,358.73% | -559.34% | -527.68% | -112.25% | 52.99% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | -616.74% | 81.52% | 45.25% | 33.83% |
| Cash from Investing | 100.00% | -616.74% | 81.52% | 45.25% | 33.83% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -54.55% | 200.00% | -- | -20.00% | -45.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 211.56% | -- | -- | -- |
| Cash from Financing | 1,722.47% | 794.54% | -- | 299.08% | -45.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 538.73% | 183.42% | 110.23% | 576.84% | 57.84% |